Novel cell-based immunization technology and functional validation of resulting antibodies
Auf einen Blick
- Projektleiter/in : Prof. Dr. Jack Rohrer
- Co-Projektleiter/in : Dr. Philippe Krebs, Prof. Dr. Frank Stenner
- Stellv. Projektleiter/in : Dr. Bruno Filippi
- Projektteam : Bettina Keller Abu Seda, Jenny Pally, Leopold von Balthazar
- Projektvolumen : CHF 1'581'835
- Projektstatus : abgeschlossen
- Drittmittelgeber : KTI (KTI-Projekt / Projekt Nr. 26019.2 PFLS-LS)
- Projektpartner : Memo Therapeutics AG
- Kontaktperson : Jack Rohrer
Beschreibung
Development of a novel immunization method in rabbits that improves the generation of antibodies against the native form of human proteins e.g. cell surface receptors. Subsequent validation of the method through functional characterization of candidate therapeutic antibodies in vitro and in vivo. The aim is the discovery of monoclonal antibodies as novel therapeutics for two different first in class targets in cancer.